PFIZER Financial Statement Analysis
|
||
|
The Revenues of PFIZER have decreased by -7.13% YoY .
The Earnings Per Share (EPS) of PFIZER has decreased by -11.64 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
PFIZER Last 5 Annual Financial Results
[BOM: 500680|NSE : PFIZER]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹2,425 Cr | ₹2,611 Cr | ₹2,239 Cr | ₹2,152 Cr | ₹2,082 Cr |
| Expenses | ₹1,616 Cr | ₹1,775 Cr | ₹1,526 Cr | ₹1,579 Cr | ₹1,516 Cr |
| Operating Profit (Excl OI) | ₹809 Cr | ₹836 Cr | ₹712 Cr | ₹573 Cr | ₹566 Cr |
| Other Income | ₹101 Cr | ₹63 Cr | ₹81 Cr | ₹184 Cr | ₹167 Cr |
| Interest | ₹13 Cr | ₹11 Cr | ₹15 Cr | ₹11 Cr | ₹1.72 Cr |
| Depreciation | ₹106 Cr | ₹115 Cr | ₹109 Cr | ₹103 Cr | ₹71 Cr |
| Profit Before Tax | ₹824 Cr | ₹773 Cr | ₹669 Cr | ₹642 Cr | ₹660 Cr |
| Profit After Tax | ₹624 Cr | ₹613 Cr | ₹498 Cr | ₹509 Cr | ₹429 Cr |
| Earnings Per Share (Rs) | ₹120.51 | ₹136.38 | ₹133.89 | ₹108.77 | ₹111.29 |
| PAT Margin (%) | 23.81 | 24.37 | 22.56 | 22.23 | 23.66 |
| ROE(%) | 16.21 | 20.55 | 23.30 | 17.19 | 15.89 |
| ROCE(%) | 22.37 | 27.56 | 29.78 | 23.62 | 20.38 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 18,712.1 Cr |
| Revenue (TTM) | : | ₹ 2,236.1 Cr |
| Net Profit(TTM) | : | ₹ 615.5 Cr |
| EPS (TTM) | : | ₹ 134.7 |
| P/E (TTM) | : | 30.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PFIZER | -1.6% | -13.1% | -8.8% |
| SUN PHARMACEUTICAL INDUSTRIES | -4.1% | -9.8% | 8.2% |
| DIVIS LABORATORIES | -2.9% | -0.3% | 63.8% |
| CIPLA | 0.1% | 4.4% | 2.2% |
| TORRENT PHARMACEUTICALS | -1.3% | -6.5% | 19% |
| DR REDDYS LABORATORIES | -4% | -5.9% | -7.8% |
| MANKIND PHARMA | -0.8% | -7.2% | 7.2% |
| ZYDUS LIFESCIENCES | -4.2% | -7.5% | 0.8% |
| LUPIN | -5.9% | -10.7% | 23.6% |
PFIZER Revenues
[BOM: 500680|NSE : PFIZER]
| Y-o-Y | -7.13 % |
| 5 Yr CAGR | 3.89 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹2,425 Cr | -7.13 | |
| Mar2023 | ₹2,611 Cr | 16.64 | |
| Mar2022 | ₹2,239 Cr | 4.04 | |
| Mar2021 | ₹2,152 Cr | 3.37 | |
| Mar2020 | ₹2,082 Cr | - | |
PFIZER Operating Profit
[BOM: 500680|NSE : PFIZER]
| Y-o-Y | -3.23 % |
| 5 Yr CAGR | 9.36 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹809 Cr | -3.23 | |
| Mar2023 | ₹836 Cr | 17.34 | |
| Mar2022 | ₹712 Cr | 24.39 | |
| Mar2021 | ₹573 Cr | 1.25 | |
| Mar2020 | ₹566 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 4.18 % |
| 5 Yr CAGR | 5.27 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 33.36% | 4.18 | |
| Mar2023 | 32.02% | 0.63 | |
| Mar2022 | 31.82% | 19.53 | |
| Mar2021 | 26.62% | -2.02 | |
| Mar2020 | 27.17% | - | |
PFIZER Profit After Tax
[BOM: 500680|NSE : PFIZER]
| Y-o-Y | 1.86 % |
| 5 Yr CAGR | 9.81 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹624 Cr | 1.86 | |
| Mar2023 | ₹613 Cr | 23.10 | |
| Mar2022 | ₹498 Cr | -2.26 | |
| Mar2021 | ₹509 Cr | 18.66 | |
| Mar2020 | ₹429 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -2.30 % |
| 5 Yr CAGR | 0.16 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 23.81 % | -2.30 | |
| Mar2023 | 24.37 % | 8.02 | |
| Mar2022 | 22.56 % | 1.48 | |
| Mar2021 | 22.23 % | -6.04 | |
| Mar2020 | 23.66 % | - | |
PFIZER Earnings Per Share (EPS)
[BOM: 500680|NSE : PFIZER]
| Y-o-Y | -11.64 % |
| 5 Yr CAGR | 2.01 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹121 | -11.64 | |
| Mar2023 | ₹136 | 1.86 | |
| Mar2022 | ₹134 | 23.09 | |
| Mar2021 | ₹109 | -2.26 | |
| Mar2020 | ₹111 | - | |
PFIZER Return on Capital Employed (ROCE)
[BOM: 500680|NSE : PFIZER]
| Y-o-Y | -18.83 % |
| 5 Yr CAGR | 2.36 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 22.37% | -18.83 | |
| Mar2023 | 27.56% | -7.45 | |
| Mar2022 | 29.78% | 26.08 | |
| Mar2021 | 23.62% | 15.90 | |
| Mar2020 | 20.38% | - | |
PFIZER Share Price vs Sensex
| Current Share Price | : | ₹4,094.6 |
| Current MarketCap | : | ₹ 18,712.1 Cr |
| Updated EOD on | : | Feb 21,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -1.6% |
-13.1% |
-8.8% |
| SENSEX | -0.8% |
-1.6% |
3.1% |
PFIZER related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 400 MIDSMALLCAP INDEX | 1.4% | -7.9% | 0.8% |
| BSE 250 SMALLCAP INDEX | 1.3% | -9.9% | -3.1% |
| BSE MIDSMALLCAP | 1.3% | -8.8% | 0.4% |
| BSE SMALLCAP | 1% | -10.5% | -0.2% |
| BSE 500 | 0.2% | -3.9% | 1.5% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MIDSMALLCAP 400 | 1.6% | -8% | 0.9% |
| NIFTY SMALLCAP250 QUALITY 50 | 1.5% | -10% | -1.2% |
| NIFTY SMALLCAP 250 | 1.3% | -10.2% | -2.8% |
| NIFTY500 MULTICAP 50:25:25 | 0.6% | -5.4% | 1.6% |
| NIFTY MIDSMALL HEALTHCARE | 0.4% | -8.7% | 12.3% |
You may also like the below Video Courses
FAQ about PFIZER Financials
How the annual revenues of PFIZER have changed ?
The Revenues of PFIZER have decreased by -7.13% YoY .
How the Earnings per Share (EPS) of PFIZER have changed?
The Earnings Per Share (EPS) of PFIZER has decreased by -11.64 % YoY .
Check out Intrinsic Value of Peers of PFIZER
Compare Stock Analytics of Peers of PFIZER
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
